Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 18.08.2026 SCAR LN IE000BW2B3J3 50,002.00 USD 1,542,228.64 30.843 ...
-
Ballogy Brings AI-Powered Player Development to Every Athlete With Launch of All-New App
AUSTIN, Texas--(BUSINESS WIRE)--Today Ballogy launched the most complete sports training and development app ever built for youth and amateur athletes....
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 18.08.2026 METL LN IE000UDFKE13 150,002.00 USD 5,695,453.42 37.969 ...
-
Dole plc to Participate in the Barclays 19th Annual Global Consumer Conference
DUBLIN--(BUSINESS WIRE)--Dole plc (NYSE: DOLE) today announced that members of its Executive Management team will participate in the Barclays 19th Annual Global Consumer Conference to be held in Boston, MA. Management will be available for one-on-one investor meetings on September 8, 2026. To schedule a meeting with Dole plc, please contact your Barclays representative. About Dole plc: A global leader in fresh produce, Dole plc grows, markets, and distributes an extensive variety of fresh fruit...
-
Brookwood Investment Group Expands Executive Leadership as Firm Advances Professional Advisor Partnership Model
PHOENIX--(BUSINESS WIRE)--Brookwood Investment Group, a nationally recognized, independent RIA firm committed to redefining the advisor independence through an advisor-centric, fiduciary-first platform, is building a platform that combines institutional scale with something increasingly valuable in an age of accelerating technology: the human professional. As technology becomes more powerful, the professionals using it will matter more. The firm is expanding its leadership and institutional cap...
-
The Princeton Review Ranks JWMI #4 Online MBA Program
WASHINGTON--(BUSINESS WIRE)--The Jack Welch Management Institute at Strayer University (JWMI) has placed #4 in The Princeton Review’s list of Top 50 Online MBA Programs for 2027....
-
Bamboo Health and Texas Health Services Authority Expand Access to Real-Time Event Notifications Across 75% of Texas Acute Care Facilities
AUSTIN, Texas--(BUSINESS WIRE)--Bamboo Health, a leader in care navigation and care coordination, and the Texas Health Services Authority (THSA), operator of HIETexas, today announced a live bidirectional data-sharing partnership that expands access to real-time patient event notifications across approximately 75% of Texas acute care facilities. The partnership enables healthcare organizations connected to either Bamboo Health or THSA to receive a broader stream of real-time admission, discharg...
-
AVIAT STOCK ALERT: Kaskela Law LLC Announces Shareholder Investigation of Aviat Networks Inc. (NASDAQ: AVNW) and Encourages Current AVNW Stockholders to Contact the Firm
NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law announces that it is investigating Aviat Networks, Inc. (Nasdaq: AVNW) (“Aviat”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Aviat and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors in connection with recent corporate actions. Aviat shareholders who would like to learn more about this investigation and their legal...
-
Wrango Finds 32% more HCPs with Supply-Side Targeting via OpenXSelect™
NEW YORK--(BUSINESS WIRE)--Wrango, the healthcare marketing platform purpose-built for verified healthcare provider (HCP) activation and clinical measurement, and OpenX, The Intelligent SSP™, today released results from a controlled test across specialty pharma campaigns that shows supply-side targeting — not audience definition alone — can influence how much of a physician audience is actually reachable. The study, run across multiple specialty pharma brand campaigns, compared multiple paths t...
-
KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing
PITTSBURGH--(BUSINESS WIRE)--KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic immunotherapy programs, today announced the closing of a $14 million extension of its Series A financing. The financing was led by Company K Partners, with participation from SV Investment, Flexus Partners, as well as continued support from existing investors including affiliates of Nextrans and Quad Investment Management. The financing bring...